Quarterly report [Sections 13 or 15(d)]

Consolidated Balance Sheets

v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 746 $ 2,338
Prepaid expenses and other current assets 212 219
Deferred offering costs 424 0
Total Current Assets 1,382 2,557
Operating lease right-of-use assets 91 99
Intangible asset 2,039 2,039
Other assets 3 3
TOTAL ASSETS 3,515 4,698
Current Liabilities    
Accounts payable and accrued liabilities 2,509 1,676
Due to related parties 23 61
Operating lease liabilities - current portion 36 35
Advances from investors 236 0
Total Current Liabilities 2,804 1,772
Operating Lease, Liability, Noncurrent 59 69
TOTAL LIABILITIES 2,863 1,841
STOCKHOLDERS' EQUITY    
Preferred Stock, par value $0.001, 416,667 shares authorized, 0 shares issued and outstanding as of March 31, 2025 and December 31, 2024 0 0
Common Stock, par value $0.001, 50,000,000 shares authorized and 3,281,032 shares issued and outstanding as of March 31, 2025, and December 31, 2024 3 3
Additional paid-in capital 53,384 53,192
Accumulated deficit (52,508) (50,136)
Accumulated other comprehensive loss (227) (202)
TOTAL STOCKHOLDERS' EQUITY 652 2,857
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,515 $ 4,698